---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-058525"
form_type: "8-K"
ticker: "OCUL"
cik: "0001393434"
company_name: "OCULAR THERAPEUTIX, INC"
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T12:48:53.446052+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# SOL-R enrollment complete; shareholders approve 8.75M share increase and CEO award

## Summary
- SOL-R Phase 3 trial for AXPAXLI (wet AMD) completed enrollment on May 31, 2025; target randomization of at least 555 subjects.
- Stockholders approved Amendment No. 4 increasing 2021 Stock Incentive Plan shares by 8,750,000 shares.
- Stockholders approved Amended and Restated ESPP increasing shares by 2,000,000 and removing evergreen provision.
- CEO Dr. Dugel granted performance stock option award for up to 2,750,000 shares at $7.44/share, vesting on stock price hurdles.
- Certificate of Amendment filed to provide officer exculpation (limitation of liability) per Delaware law.

## SEC filing metadata
- accession: 0001104659-25-058525
- form_type: 8-K
- ticker: OCUL
- cik: 0001393434
- company_name: OCULAR THERAPEUTIX, INC
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1393434/000110465925058525/0001104659-25-058525-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1393434/000110465925058525/tm2517563d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-058525
- JSON: https://secwatch.observer/filing/0001104659-25-058525.json
- Plain text: https://secwatch.observer/filing/0001104659-25-058525.txt

## Key facts
- Governance Changes
  OCULAR THERAPEUTIX, INC: Amended restated certificate of incorporation to provide for officer exculpation (effective 2025-06-11).
  - Change: charter amendment
  - Effective: 2025-06-11
  source text: At the 2025 Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), to update its existing director exculpation provision to include the exculpation of certain of the Company’s senior corporate officers, subject to specified limitations. The Company filed the Certificate of Amendment, which was effective upon filing, with the Secretary of State of the State of Delaware on June 11, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1393434/000110465925058525/0001104659-25-058525-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.